Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)

Tadakatsu Nakamura,1 Tomoko Kubota,1 Atsushi Iwakaji,1 Masayoshi Imada,1 Margit Kapás,2 Yasunori Morio1 1Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan; 2Developmental Drug Metabolism and Pharmacokinetics, Gedeon Richter Plc, Budapest, Hungary Purpose: Cari...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Nakamura T (Dahkki), Kubota T (Dahkki), Iwakaji A (Dahkki), Imada M (Dahkki), Kapás M (Dahkki), Morio Y (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Dove Medical Press, 2016-01-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis